Does EVEROLIMUS Cause Therapy cessation? 243 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 243 reports of Therapy cessation have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.6% of all adverse event reports for EVEROLIMUS.
243
Reports of Therapy cessation with EVEROLIMUS
0.6%
of all EVEROLIMUS reports
1
Deaths
68
Hospitalizations
How Dangerous Is Therapy cessation From EVEROLIMUS?
Of the 243 reports, 1 (0.4%) resulted in death, 68 (28.0%) required hospitalization, and 2 (0.8%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 243 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which EVEROLIMUS Alternatives Have Lower Therapy cessation Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE